Literature DB >> 29660379

Nervous system and primary liver cancer.

Seogsong Jeong1, Bo Zheng2, Hongyang Wang3, Qiang Xia4, Lei Chen5.   

Abstract

Recent advances have found irregular activities of the nervous system-associated factors in the development and progression of primary liver cancer. These factors contributed in the regulation of migration, proliferation, and apoptosis of cancer cells, and took a role in modulating invasion, metastasis, and recurrence after curative treatment. In clinical researches, neural-related factors were found to be significant prognostic factors, suggesting that the interactions between nervous system and primary liver cancer are indispensable in understanding underlying biological mechanisms. Herein, we reviewed up-to-date achievements in this area and the future perspectives of the interactions between the nervous system and primary liver cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Nervous system; Neural regulation; Neurotransmitters; Prognostic factors

Mesh:

Substances:

Year:  2018        PMID: 29660379     DOI: 10.1016/j.bbcan.2018.04.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  10 in total

1.  SLC18A3 promoted renal cancer development through acetylcholine/cAMP signaling.

Authors:  Peng Tie; Ji Cheng; Miao-Xin Xue; Jian Yin; Guo Fu; Wan-Li Duan
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

2.  Different anaesthesia methods affect the development of hepatoblastoma after platelet activation.

Authors:  Guoxiong Fei; Meili Cao; Chunlin Ge; Yan Xie
Journal:  Int J Exp Pathol       Date:  2021-01-07       Impact factor: 1.925

3.  A Contemporary Approach to Diagnosis and Treatment of Combined Hepatocellular-Cholangiocarcinoma.

Authors:  Olga Raevskaya; Henry Appelman; Nataliya Razumilava
Journal:  Curr Hepatol Rep       Date:  2020-10-31

4.  Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma.

Authors:  Jian Fan; Jun Li; Shicheng Guo; Chengcheng Tao; Haikun Zhang; Wenjing Wang; Ying Zhang; Dake Zhang; Shigang Ding; Changqing Zeng
Journal:  Clin Epigenetics       Date:  2020-04-21       Impact factor: 6.551

5.  Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E.

Authors:  Ying Zhang; Qingsong Tie; Zhiwei Bao; Zhi Shao; Lan Zhang
Journal:  Comput Math Methods Med       Date:  2021-11-13       Impact factor: 2.238

6.  Efficacy of liver cancer microwave ablation through ultrasonic image guidance under deep migration feature algorithm.

Authors:  Changkong Ye; Wenyan Zhang; Zijuan Pang; Wei Wang
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

7.  Effect of Radiofrequency Ablation with Interventional Therapy of Hepatic Artery on the Recurrence of Primary Liver Cancer and the Analysis of Influencing Factors.

Authors:  Sishuo Zhang; Ge Zhao; Honglin Dong
Journal:  J Oncol       Date:  2021-10-13       Impact factor: 4.375

Review 8.  Emerging Roles of the Nervous System in Gastrointestinal Cancer Development.

Authors:  Chunhua Wan; Xiaoqin Yan; Baoying Hu; Xinhua Zhang
Journal:  Cancers (Basel)       Date:  2022-07-30       Impact factor: 6.575

9.  On the Core Prescriptions and Their Mechanisms of Traditional Chinese Medicine in Hepatitis B, Liver Cirrhosis, and Liver Cancer Treatment.

Authors:  Zhendong Wang; Yong Zhang; Qiuyun Zhang; Qiang Ao; Changyong Luo; Bochuan Wang; Chen Bai; Xueyi Ge; Yuhan Wang; Jing Wang; Ying Qian; He Yu; Xiaohong Gu
Journal:  J Oncol       Date:  2022-09-23       Impact factor: 4.501

10.  Comparative analysis of the efficacy and accuracy of magnetic resonance imaging (MRI) and contrast-enhanced CT for residual and new lesions after transcatheter arterial chemoembolization (TACE) in patients with primary liver cancer.

Authors:  Liang Shao; Xiaolei Wang; Yongtao Yu; Jiangwei Xie
Journal:  Transl Cancer Res       Date:  2021-08       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.